Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Stroke

Free Subscription Articles published in Int J Cardiol Retrieve available abstracts of 186 articles: HTML format Text format

Single Articles

April 2019
1. SORIGUE M, Sarrate E, Miljkovic MD
   Anticoagulation for atrial fibrillation in patients with active cancer.
   Int J Cardiol. 2019;280:98.
   PubMed     Text format    
   
   
   March 2019
2. MOSCARELLI M
   CT scan in minimally invasive surgery: A call to safety.
   Int J Cardiol. 2019;278:307-308.
   PubMed     Text format    
   
   
   
3. REIFFEL JA
   Apples will never be oranges, but when you go fishing you may get a bite.
   Int J Cardiol. 2019;278:155-156.
   PubMed     Text format    
   
   
   February 2019
4. DE GREGORIO MA, Guirola JA, Kuo WT, Serrano C, et al
   Catheter-directed aspiration thrombectomy and low-dose thrombolysis for patients with acute unstable pulmonary embolism: Prospective outcomes from a PE registry.
   Int J Cardiol. 2019 Feb 28. pii: S0167-5273(18)36761.
   PubMed     Text format     Abstract available
   
   
   January 2019
5. GIUSTOZZI M, Vedovati MC, Verso M, Scrucca L, et al
   Patients aged 90years or older with atrial fibrillation treated with oral anticoagulants: A multicentre observational study.
   Int J Cardiol. 2019 Jan 25. pii: S0167-5273(18)37162.
   PubMed     Text format     Abstract available
   
   
   
6. GOROG DA
   Lowering the risk of stroke prevention: Managing bleeding complications.
   Int J Cardiol. 2019;274:351-352.
   PubMed     Text format    
   
   
   December 2018
7. CRISTINA V
   Oxidative stress and cardiovascular risk prediction: The long way towards a "radical" perspective.
   Int J Cardiol. 2018;273:252-253.
   PubMed     Text format    
   
   
   
8. PICKETT CA, Villines TC, Resar JR, Hulten EA, et al
   Cost effectiveness and clinical efficacy of patent foramen ovale closure as compared to medical therapy in cryptogenic stroke patients: A detailed cost analysis and meta-analysis of randomized controlled trials.
   Int J Cardiol. 2018;273:74-79.
   PubMed     Text format     Abstract available
   
   
   
9. SPARTALIS M, Tzatzaki E, Paschou SA, Spartalis E, et al
   Type 1 diabetes is associated with increased risk of atrial fibrillation.
   Int J Cardiol. 2018 Dec 4. pii: S0167-5273(18)34989.
   PubMed     Text format    
   
   
   November 2018
10. FERREIRO JL, Gomez-Hospital JA
    Antithrombotic therapy after acute coronary syndromes in patients with atrial fibrillation: Shouldn't we pay more attention to the risk of ischemic and thromboembolic events?
    Int J Cardiol. 2018 Nov 29. pii: S0167-5273(18)36183.
    PubMed     Text format    
    
    
    
11. WANG H, Wang S, Sun Y
    Could red blood cell distribution width predict high CHADS2 and CHADS2-VASC score in adults with atrial fibrillation? A focus on the general population.
    Int J Cardiol. 2018;271:345.
    PubMed     Text format    
    
    
    
12. LI J, Wang X, Sun M, Yan G, et al
    "Rebound" hypercoagulability after interruption of anticoagulation in patients with atrial fibrillation.
    Int J Cardiol. 2018;271:119.
    PubMed     Text format    
    
    
    
13. STRENG KW, Nauta JF, Hillege HL, Anker SD, et al
    Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction.
    Int J Cardiol. 2018;271:132-139.
    PubMed     Text format     Abstract available
    
    
    
14. POLZIN A, Dannenberg L, Wolff G, Zeus T, et al
    Increased risk of myocardial infarction with dabigatran etexilate: Fact or fiction? A critical meta-analysis from integrating randomized controlled trials and real-world studies: Wine or spritzer?
    Int J Cardiol. 2018;270:82.
    PubMed     Text format    
    
    
    October 2018
15. CALDEIRA D
    Non-vitamin K antagonist oral anticoagulants (NOACs) in cardioversions: The past, the present and the future.
    Int J Cardiol. 2018;268:149-150.
    PubMed     Text format    
    
    
    September 2018
16. GUTTMANN OP
    Atrial fibrillation and thromboembolism in hypertrophic cardiomyopathy - An underestimated risk.
    Int J Cardiol. 2018 Sep 19. pii: S0167-5273(18)35180.
    PubMed     Text format    
    
    
    
17. CILIBERTI G, Coiro S, Tritto I, Benedetti M, et al
    Predictors of poor clinical outcomes in patients with acute myocardial infarction and non-obstructed coronary arteries (MINOCA).
    Int J Cardiol. 2018;267:41-45.
    PubMed     Text format     Abstract available
    
    
    
18. KIM H, Senecal C, Lewis B, Prasad A, et al
    Natural history and predictors of mortality of patients with Takotsubo syndrome.
    Int J Cardiol. 2018;267:22-27.
    PubMed     Text format     Abstract available
    
    
    
19. VAN DOORN S, Rutten FH, O'Flynn CM, Oudega R, et al
    Effectiveness of CHA2DS2-VASc based decision support on stroke prevention in atrial fibrillation: A cluster randomised trial in general practice.
    Int J Cardiol. 2018 Sep 8. pii: S0167-5273(18)33685.
    PubMed     Text format     Abstract available
    
    
    
20. CHEN HL, Cai JY, Zha ML, Liu K, et al
    Does CHA2DS2-VASc score have the discrimination and calibration power in predicting renal function decline?
    Int J Cardiol. 2018;266:161.
    PubMed     Text format    
    
    
    
21. WANG S, Su Z, Zhang Y
    The true prevalence of inappropriate anticoagulation therapy in Chinese patients with a CHA2DS2-VASc score of 0.
    Int J Cardiol. 2018;266:159.
    PubMed     Text format    
    
    
    
22. KADHIM K, Lau DH, Linz D, Sanders P, et al
    Improved survival and reduced stroke risk in patients with atrial fibrillation: Is catheter ablation winning the rhythm-control race?
    Int J Cardiol. 2018;266:153-154.
    PubMed     Text format    
    
    
    
23. PASCERI V, Pelliccia F, Bressi E, Mantione L, et al
    Net clinical benefit of patent foramen ovale closure in patients with cryptogenic stroke: Meta-analysis and meta-regression of randomized trials.
    Int J Cardiol. 2018;266:75-80.
    PubMed     Text format     Abstract available
    
    
    
24. BARRA S, Baran J, Narayanan K, Boveda S, et al
    Association of catheter ablation for atrial fibrillation with mortality and stroke: A systematic review and meta-analysis.
    Int J Cardiol. 2018;266:136-142.
    PubMed     Text format     Abstract available
    
    
    August 2018
25. HIGASHI Y
    Does renal function have incremental predictive value of stroke in atrial fibrillation?
    Int J Cardiol. 2018 Aug 29. pii: S0167-5273(18)34620.
    PubMed     Text format    
    
    
    
26. CHOI YJ, Choi EK, Han KD, Jung JH, et al
    Temporal trends of the prevalence and incidence of atrial fibrillation and stroke among Asian patients with hypertrophic cardiomyopathy: A nationwide population-based study.
    Int J Cardiol. 2018 Aug 11. pii: S0167-5273(18)33740.
    PubMed     Text format     Abstract available
    
    
    
27. MULDER BA, Geelhoed B, van der Harst P, Spronk HM, et al
    Plasminogen activator inhibitor-1 and tissue plasminogen activator and incident AF: Data from the PREVEND study.
    Int J Cardiol. 2018 Aug 10. pii: S0167-5273(18)34407.
    PubMed     Text format    
    
    
    
28. XUAN Y, Gao X, Holleczek B, Brenner H, et al
    Prediction of myocardial infarction, stroke and cardiovascular mortality with urinary biomarkers of oxidative stress: Results from a large cohort study.
    Int J Cardiol. 2018 Aug 3. pii: S0167-5273(18)33360.
    PubMed     Text format     Abstract available
    
    
    
29. FISCHER Q, Georges JL, Le Feuvre C, Sharma A, et al
    Optimal long-term antithrombotic treatment of patients with stable coronary artery disease and atrial fibrillation: "OLTAT registry".
    Int J Cardiol. 2018;264:64-69.
    PubMed     Text format     Abstract available
    
    
    
30. RUBBOLI A
    Oral anticoagulation alone for concomitant stable coronary artery disease and atrial fibrillation: A definitive strategy?
    Int J Cardiol. 2018;264:95-96.
    PubMed     Text format    
    
    
    
31. MARIN F, Roldan V
    Oral anticoagulation and comorbidities; too many details for clinical practice?
    Int J Cardiol. 2018;264:93-94.
    PubMed     Text format    
    
    
    
32. FRIBERG L
    Safety of apixaban in combination with dronedarone in patients with atrial fibrillation.
    Int J Cardiol. 2018;264:85-90.
    PubMed     Text format     Abstract available
    
    
    
33. PASTORI D, Lip GYH, Farcomeni A, Del Sole F, et al
    Incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants.
    Int J Cardiol. 2018;264:58-63.
    PubMed     Text format     Abstract available
    
    
    
34. PICHLER G, Amigo N, Tellez-Plaza M, Pardo-Cea MA, et al
    LDL particle size and composition and incident cardiovascular disease in a South-European population: The Hortega-Liposcale Follow-up Study.
    Int J Cardiol. 2018;264:172-178.
    PubMed     Text format     Abstract available
    
    
    July 2018
35. VEDOVATI MC, Giustozzi M, Verdecchia P, Pierpaoli L, et al
    Patients with cancer and atrial fibrillation treated with doacs: A prospective cohort study.
    Int J Cardiol. 2018 Jul 29. pii: S0167-5273(18)32719.
    PubMed     Text format     Abstract available
    
    
    
36. MCALISTER FA, Wiebe N, Ronksley PE, Healey JS, et al
    Although non-stroke outcomes are more common, stroke risk scores can be used for prediction in patients with atrial fibrillation.
    Int J Cardiol. 2018 Jul 27. pii: S0167-5273(18)33059.
    PubMed     Text format     Abstract available
    
    
    
37. RIVA L, Ageno W, Di Pasquale G, Agnelli G, et al
    Antithrombotic therapy for patients with an indication for oral anticoagulation undergoing percutaneous coronary intervention with stent: The case of venous thromboembolism.
    Int J Cardiol. 2018 Jul 26. pii: S0167-5273(18)32356.
    PubMed     Text format     Abstract available
    
    
    
38. KOBAYASHI N, Hata N, Tsurumi M, Shibata Y, et al
    Relation of coronary culprit lesion morphology determined by optical coherence tomography and cardiac outcomes to preinfarction angina in patients with acute myocardial infarction.
    Int J Cardiol. 2018 Jul 18. pii: S0167-5273(18)32180.
    PubMed     Text format     Abstract available
    
    
    
39. MARZONA I, Proietti M, Farcomeni A, Romiti GF, et al
    Sex differences in stroke and major adverse clinical events in patients with atrial fibrillation: A systematic review and meta-analysis of 993,600 patients.
    Int J Cardiol. 2018 Jul 9. pii: S0167-5273(18)33433.
    PubMed     Text format     Abstract available
    
    
    
40. BURLACU A, Covic A
    'Some doors are better left closed': Using LAA occluders as an alternative to warfarin in very high-risk dialysed patients with atrial fibrillation.
    Int J Cardiol. 2018;262:43-44.
    PubMed     Text format    
    
    
    June 2018
41. WENG CJ, Li CH, Liao YC, Lin CC, et al
    Rhythm control better prevents stroke and mortality than rate control strategies in patients with atrial fibrillation - A nationwide cohort study.
    Int J Cardiol. 2018 Jun 26. pii: S0167-5273(18)33463.
    PubMed     Text format     Abstract available
    
    
    
42. AYABE K, Goto S
    High rate of death in patients with atrial fibrillation -Results from EORP-AF Pilot General Registry.
    Int J Cardiol. 2018 Jun 22. pii: S0167-5273(18)33076.
    PubMed     Text format    
    
    
    
43. ANDERSSON NW, Svanstrom H, Lund M, Pasternak B, et al
    Comparative effectiveness and safety of apixaban, dabigatran, and rivaroxaban in patients with non-valvular atrial fibrillation.
    Int J Cardiol. 2018 Jun 19. pii: S0167-5273(17)35612.
    PubMed     Text format     Abstract available
    
    
    
44. SPOSATO LA, Lopes RD
    Disentangling the risk of atrial fibrillation detected after ischemic stroke (AFDAS): A real challenge in clinical practice.
    Int J Cardiol. 2018;261:99-100.
    PubMed     Text format    
    
    
    
45. HSIEH CY, Lee CH, Wu DP, Sung SF, et al
    Characteristics and outcomes of ischemic stroke in patients with known atrial fibrillation or atrial fibrillation diagnosed after stroke.
    Int J Cardiol. 2018;261:68-72.
    PubMed     Text format     Abstract available
    
    
    
46. FENDER AC, Dobrev D
    Switching off the jitters: Dabigatran as a candidate approach to halt atrial fibrillation?
    Int J Cardiol. 2018 Jun 13. pii: S0167-5273(18)33661.
    PubMed     Text format    
    
    
    
47. WANG X, Fu Q, Song F, Li W, et al
    Prevalence of atrial fibrillation in different socioeconomic regions of China and its association with stroke: Results from a national stroke screening survey.
    Int J Cardiol. 2018 Jun 2. pii: S0167-5273(18)30996.
    PubMed     Text format     Abstract available
    
    
    
48. PARASKEVAS KI, Naylor AR
    Carotid artery stenosis at the time of coronary artery bypass grafting is a risk factor but not a cause for peri-operative stroke.
    Int J Cardiol. 2018;260:23.
    PubMed     Text format    
    
    
    May 2018
49. VISZLAYOVA D, Brozman M, Langova K, Herzig R, et al
    Sonolysis in risk reduction of symptomatic and silent brain infarctions during coronary stenting (SONOREDUCE): Randomized, controlled trial.
    Int J Cardiol. 2018 May 26. pii: S0167-5273(18)30634.
    PubMed     Text format     Abstract available
    
    
    
50. FENDER AC, Dobrev D
    The not-so-sweet problem of hearts aflutter: Dissecting stroke risk in atrial fibrillation with concomitant diabetes.
    Int J Cardiol. 2018 May 19. pii: S0167-5273(18)33126.
    PubMed     Text format    
    
    
    
51. SCHOOLING CM, Luo S, Au Yeung SL, Thompson DJ, et al
    Genetic predictors of testosterone and their associations with cardiovascular disease and risk factors: A Mendelian randomization investigation.
    Int J Cardiol. 2018 May 18. pii: S0167-5273(17)36101.
    PubMed     Text format     Abstract available
    
    
    
52. ESCOBAR-ROBLEDO LA, Bayes-de-Luna A, Lupon J, Baranchuk A, et al
    Advanced interatrial block predicts new-onset atrial fibrillation and ischemic stroke in patients with heart failure: The "Bayes' Syndrome-HF" study.
    Int J Cardiol. 2018 May 18. pii: S0167-5273(18)31019.
    PubMed     Text format     Abstract available
    
    
    April 2018
53. SHENG X, Ding S, Ge H, Sun Y, et al
    Intracoronary infusion of alprostadil and nitroglycerin with targeted perfusion microcatheter in STEMI patients with coronary slow flow phenomenon.
    Int J Cardiol. 2018 Apr 25. pii: S0167-5273(17)37021.
    PubMed     Text format     Abstract available
    
    
    
54. LUO J, Li H, Qin X, Liu B, et al
    Increased risk of ischemic stroke associated with new-onset atrial fibrillation complicating acute coronary syndrome: A systematic review and meta-analysis.
    Int J Cardiol. 2018 Apr 23. pii: S0167-5273(17)37900.
    PubMed     Text format     Abstract available
    
    
    
55. SILLER-MATULA JM, Pecen L, Patti G, Lucerna M, et al
    Heart failure subtypes and thromboembolic risk in patients with atrial fibrillation: The PREFER in AF - HF substudy.
    Int J Cardiol. 2018 Apr 22. pii: S0167-5273(17)37365.
    PubMed     Text format     Abstract available
    
    
    
56. BAI J, Shen D, Wang B, Han Q, et al
    Could the CHA2DS2-VASc schema help stratify risk of ischemic stroke for individual patients with congestive heart failure?
    Int J Cardiol. 2018;257:226.
    PubMed     Text format    
    
    
    
57. JIA X, Levine GN, Birnbaum Y
    The CHA2DS2-VASc score: Not as simple as it seems.
    Int J Cardiol. 2018;257:92-96.
    PubMed     Text format     Abstract available
    
    
    
58. BARNETT AS, Cyr DD, Goodman SG, Levitan BS, et al
    Net clinical benefit of rivaroxaban compared with warfarin in atrial fibrillation: Results from ROCKET AF.
    Int J Cardiol. 2018;257:78-83.
    PubMed     Text format     Abstract available
    
    
    
59. LAMBIASE PD
    AF stroke risk stratification-can we do better?
    Int J Cardiol. 2018;257:108-109.
    PubMed     Text format    
    
    
    
60. MIRZADA N, Ladenvall P, Hansson PO, Eriksson P, et al
    Quality of life after percutaneous closure of patent foramen ovale in patients after cryptogenic stroke compared to a normative sample.
    Int J Cardiol. 2018;257:46-49.
    PubMed     Text format     Abstract available
    
    
    
61. LI B, Sun C, Qin F, Liu N, et al
    Could direct oral anticoagulants be an alternative to vitamin K antagonists in patients with hypertrophic cardiomyopathy and atrial fibrillation?
    Int J Cardiol. 2018;256:39.
    PubMed     Text format    
    
    
    March 2018
62. PICCOLO R, Franzone A, Siontis GCM, Stortecky S, et al
    Patent foramen ovale closure vs. medical therapy for recurrent stroke prevention: Evolution of treatment effect during follow-up.
    Int J Cardiol. 2018;255:29-31.
    PubMed     Text format     Abstract available
    
    
    
63. BISSON A, Bodin A, Clementy N, Bernard A, et al
    Stroke, thromboembolism and bleeding in patients with atrial fibrillation according to the EHRA valvular heart disease classification.
    Int J Cardiol. 2018 Mar 7. pii: S0167-5273(18)30084.
    PubMed     Text format     Abstract available
    
    
    
64. MUJOVIC N, Potpara TS
    Optimizing bleeding risk assessment in patients with atrial fibrillation: To score or not to score?
    Int J Cardiol. 2018;254:164-166.
    PubMed     Text format    
    
    
    February 2018
65. GOETTE A
    Atrial fibrillation and stroke risk factors induce decline in creatinine clearance: Is there a specific "fibrillatory kidney disease"?
    Int J Cardiol. 2018;253:82-83.
    PubMed     Text format    
    
    
    
66. SHIMOKAWA H, Yamashita T, Uchiyama S, Kitazono T, et al
    The EXPAND study: Efficacy and safety of rivaroxaban in Japanese patients with non-valvular atrial fibrillation.
    Int J Cardiol. 2018 Feb 3. pii: S0167-5273(18)30592.
    PubMed     Text format     Abstract available
    
    
    
67. FAUCHIER L, Bisson A, Genet T
    Antiplatelet therapy, vitamin K antagonist and low time in therapeutic range in patients with atrial fibrillation: Highway to bleed.
    Int J Cardiol. 2018;252:110-111.
    PubMed     Text format    
    
    
    January 2018
68. CAVALLARI I, Ruff CT, Nordio F, Deenadayalu N, et al
    Clinical events after interruption of anticoagulation in patients with atrial fibrillation: An analysis from the ENGAGE AF-TIMI 48 trial.
    Int J Cardiol. 2018 Jan 26. pii: S0167-5273(17)35262.
    PubMed     Text format     Abstract available
    
    
    
69. JOLOBE OMP
    Proposed rationale for anticoagulants in nonvalvular atrial fibrillation with zero CHA2DS2-Vasc score.
    Int J Cardiol. 2018 Jan 21. pii: S0167-5273(17)36194.
    PubMed     Text format    
    
    
    
70. QIN F, Liu N, Liu C, Bai F, et al
    Could excessive atrial ectopic activity be an independent risk factor for ischemic stroke?
    Int J Cardiol. 2018;251:53.
    PubMed     Text format    
    
    
    
71. BAI R
    Percutaneous left atrial appendage closure versus oral anticoagulant: A bird in the hand is worth two in the bush?
    Int J Cardiol. 2018;251:51-52.
    PubMed     Text format    
    
    
    
72. FERLINI M, Rossini R
    Left atrial appendage closure: Six reasons why I wouldn't choose a percutaneous closure for my appendage.
    Int J Cardiol. 2018;251:42-44.
    PubMed     Text format     Abstract available
    
    
    
73. WAKABAYASHI K, Ikeda N, Kajimoto K, Minami Y, et al
    Trends and predictors of non-cardiovascular death in patients hospitalized for acute heart failure.
    Int J Cardiol. 2018;250:164-170.
    PubMed     Text format     Abstract available
    
    
    December 2017
74. WONG CX
    Atrial fibrillation, hip fracture, and oral anticoagulation therapy.
    Int J Cardiol. 2017;249:260.
    PubMed     Text format    
    
    
    
75. CERIT L
    Atrial fibrillation, hip fracture, and oral anticoagulant therapy.
    Int J Cardiol. 2017;249:259.
    PubMed     Text format    
    
    
    
76. GOETTE A
    Why is there still undertreatment with oral anticoagulants in elderly high risk patients with AF?
    Int J Cardiol. 2017;249:247-248.
    PubMed     Text format    
    
    
    November 2017
77. MAKOWSKI M, Baj Z
    New biomarkers in risk stratification in patients with atrial fibrillation.
    Int J Cardiol. 2017;247:19.
    PubMed     Text format    
    
    
    
78. BARKAS F, Elisaf M, Liberopoulos E
    Low high-density lipoprotein cholesterol levels improve the performance of the CHADS2 and CHA2DS2-VASc scores for the prediction of new-onset atrial fibrillation.
    Int J Cardiol. 2017;247:18.
    PubMed     Text format    
    
    
    
79. QIN F, Zhao Y, He B, Liu Q, et al
    Could low high-density lipoprotein cholesterol levels improve the performance of the CHADS2 and CHA2DS2-VASc scores in predicting new atrial fibrillation?
    Int J Cardiol. 2017;247:17.
    PubMed     Text format    
    
    
    
80. EL-BATTRAWY I, Borggrefe M, Akin I
    Atrial fibrillation as a risk factor for worse outcome in acute coronary syndrome.
    Int J Cardiol. 2017;246:53.
    PubMed     Text format    
    
    
    October 2017
81. WIYEH AB, Ochodo EA, Wiysonge CS, Kakia A, et al
    A systematic review of the efficacy and safety of intrapericardial fibrinolysis in patients with pericardial effusion.
    Int J Cardiol. 2017 Oct 26. pii: S0167-5273(17)35919.
    PubMed     Text format     Abstract available
    
    
    
82. PAGOLA J, Juega J, Francisco-Pascual J, Moya A, et al
    Yield of atrial fibrillation detection with Textile Wearable Holter from the acute phase of stroke: Pilot study of Crypto-AF registry.
    Int J Cardiol. 2017 Oct 22. pii: S0167-5273(17)33896.
    PubMed     Text format     Abstract available
    
    
    
83. TSE G, Lip GYH, Liu T
    The CHADS2 and CHA2DS2-VASc scores for predicting healthcare utilization and outcomes: Observations on the Appropriate Use and Misuse of Risk scores.
    Int J Cardiol. 2017;245:181-182.
    PubMed     Text format    
    
    
    
84. WANG S, Li J, Yan G, Zhang Y, et al
    New biomarkers' improvement of thrombogenesis risk stratification in patients with atrial fibrillation and CHA2DS2-VASc Score 1.
    Int J Cardiol. 2017;244:296.
    PubMed     Text format    
    
    
    September 2017
85. DENAS G, Gennaro N, Ferroni E, Fedeli U, et al
    Effectiveness and safety of oral anticoagulation with non-vitamin K antagonists compared to well-managed vitamin K antagonists in naive patients with non-valvular atrial fibrillation: Propensity score matched cohort study.
    Int J Cardiol. 2017 Sep 18. pii: S0167-5273(17)32377.
    PubMed     Text format     Abstract available
    
    
    
86. SAMBOLA A, Ruiz-Meana M, Barba I, Del Blanco BG, et al
    Glycative and oxidative stress are associated with altered thrombus composition in diabetic patients with ST-elevation myocardial infarction.
    Int J Cardiol. 2017;243:9-14.
    PubMed     Text format     Abstract available
    
    
    
87. TOCCI G, Presta V
    Increased arterial stiffness and haemorrhagic transformation in ischaemic stroke after thrombolysis: A new marker of risk for cerebrovascular events and complications.
    Int J Cardiol. 2017;243:471-472.
    PubMed     Text format    
    
    
    
88. ACAMPA M, Camarri S, Lazzerini PE, Guideri F, et al
    Increased arterial stiffness is an independent risk factor for hemorrhagic transformation in ischemic stroke undergoing thrombolysis.
    Int J Cardiol. 2017;243:466-470.
    PubMed     Text format     Abstract available
    
    
    
89. AYUBI E, Safiri S
    Comments on CHA2DS2-VASc score in the prediction of ischemic bowel disease among patients with atrial fibrillation.
    Int J Cardiol. 2017;242:9.
    PubMed     Text format    
    
    
    
90. HU WS, Lin CL
    Reply: CHA2DS2-VASc score in the prediction of ischemic bowel disease among patients with atrial fibrillation: Insights from a nationwide cohort.
    Int J Cardiol. 2017;242:10.
    PubMed     Text format    
    
    
    August 2017
91. GLOEKLER S, Saw J, Koskinas KC, Kleinecke C, et al
    Left atrial appendage closure for prevention of death, stroke, and bleeding in patients with nonvalvular atrial fibrillation.
    Int J Cardiol. 2017 Aug 26. pii: S0167-5273(17)33620.
    PubMed     Text format     Abstract available
    
    
    July 2017
92. KANG SH, Kim J, Park JJ, Oh IY, et al
    Risk of stroke in congestive heart failure with and without atrial fibrillation.
    Int J Cardiol. 2017 Jul 20. pii: S0167-5273(17)30701.
    PubMed     Text format     Abstract available
    
    
    
93. ROSSELLO X, Huo Y, Pocock S, de Werf FV, et al
    Global geographical variations in ST-segment elevation myocardial infarction management and post-discharge mortality.
    Int J Cardiol. 2017 Jul 15. pii: S0167-5273(17)32845.
    PubMed     Text format     Abstract available
    
    
    
94. CERIT L
    Dual risk stratification for dual antiplatelet therapy: SYNTAX and CHA2DS2-VASc score.
    Int J Cardiol. 2017;239:22.
    PubMed     Text format    
    
    
    
95. NOSEWORTHY PA, Yao X, Gersh BJ, Hargraves I, et al
    Long-term stroke and bleeding risk in patients with atrial fibrillation treated with oral anticoagulants in contemporary practice: Providing evidence for shared decision-making.
    Int J Cardiol. 2017 Jul 14. pii: S0167-5273(17)32969.
    PubMed     Text format     Abstract available
    
    
    June 2017
96. LAVI S, Iqbal J, Cairns JA, Cantor WJ, et al
    Bare metal versus drug eluting stents for ST-segment elevation myocardial infarction in the TOTAL trial.
    Int J Cardiol. 2017 Jun 29. pii: S0167-5273(17)33508.
    PubMed     Text format     Abstract available
    
    
    
97. VIDALE S, Arnaboldi M, Bosio V, Corrado G, et al
    Short-term air pollution exposure and cardiovascular events: A 10-year study in the urban area of Como, Italy.
    Int J Cardiol. 2017 Jun 15. pii: S0167-5273(17)31683.
    PubMed     Text format     Abstract available
    
    
    
98. CAPPELLARI M, Bovi P
    Direct oral anticoagulants in patients with cervical artery dissection and cerebral venous thrombosis. A case series and review of the literature.
    Int J Cardiol. 2017 Jun 13. pii: S0167-5273(17)32629.
    PubMed     Text format     Abstract available
    
    
    
99. HOLDA MK, Koziej M, Wszolek K, Pawlik W, et al
    Left atrial accessory appendages, diverticula, and left-sided septal pouch in multi-slice computed tomography. Association with atrial fibrillation and cerebrovascular accidents.
    Int J Cardiol. 2017 Jun 13. pii: S0167-5273(17)32424.
    PubMed     Text format     Abstract available
    
    
    
100. ZIEGLER PD, Rogers JD, Ferreira SW, Nichols AJ, et al
     Long-term detection of atrial fibrillation with insertable cardiac monitors in a real-world cryptogenic stroke population.
     Int J Cardiol. 2017 Jun 10. pii: S0167-5273(17)32506.
     PubMed     Text format     Abstract available
     
     
     
101. CARMO J, Ferreira J, Costa F, Carmo P, et al
     Non-vitamin K antagonist oral anticoagulants compared with warfarin at different levels of INR control in atrial fibrillation: A meta-analysis of randomized trials.
     Int J Cardiol. 2017 Jun 3. pii: S0167-5273(17)31600.
     PubMed     Text format     Abstract available
     
     
     
102. ACHILLES A, Mohring A, Dannenberg L, Piayda K, et al
     Analgesic medication with dipyrone in patients with coronary artery disease: Relation to MACCE.
     Int J Cardiol. 2017;236:76-81.
     PubMed     Text format     Abstract available
     
     
     
103. MEFFORD M, Safford MM, Muntner P, Durant RW, et al
     Insurance, self-reported medication adherence and LDL cholesterol: The REasons for Geographic And Racial Differences in Stroke study.
     Int J Cardiol. 2017;236:462-465.
     PubMed     Text format     Abstract available
     
     
     
104. CHAIKRIANGKRAI K, Jhun HY, Palamaner Subash Shantha G, Bin Abdulhak A, et al
     Coronary artery calcium score as a predictor for incident stroke: Systematic review and meta-analysis.
     Int J Cardiol. 2017;236:473-477.
     PubMed     Text format     Abstract available
     
     
     May 2017
105. MATUSIK PT, Matusik PS, Kornacewicz-Jach Z, Malecka B, et al
     Elevated NT-proBNP is associated with unfavorably altered plasma fibrin clot properties in atrial fibrillation.
     Int J Cardiol. 2017 May 16. pii: S0167-5273(17)31785.
     PubMed     Text format     Abstract available
     
     
     
106. BECATTINI C, Franco L, Agnelli G
     Risk of death in patients with major bleedings while on treatment with oral anticoagulants.
     Int J Cardiol. 2017;235:200.
     PubMed     Text format    
     
     
     
107. ALEXOPOULOS D
     Delayed onset of novel P2Y12 receptor antagonists action post fibrinolysis.
     Int J Cardiol. 2017;234:131.
     PubMed     Text format    
     
     
     
108. SUZUKI M, Takanashi S
     Assessment of clinical severity in patients with infective endocarditis with cardio-embolic strokes.
     Int J Cardiol. 2017;234:140.
     PubMed     Text format    
     
     
     April 2017
109. KWOK CS, Bagur R, Rashid M, Lavi R, et al
     Aortic stenosis and non-cardiac surgery: A systematic review and meta-analysis.
     Int J Cardiol. 2017 Apr 12. pii: S0167-5273(16)34897.
     PubMed     Text format     Abstract available
     
     
     March 2017
110. SHEN L, Song L, Liu B, Li H, et al
     Effects of early age at natural menopause on coronary heart disease and stroke in Chinese women.
     Int J Cardiol. 2017 Mar 30. pii: S0167-5273(16)33287.
     PubMed     Text format     Abstract available
     
     
     
111. KAIER K, Reinecke H, Schmoor C, Frankenstein L, et al
     Learning Curves Among All Patients Undergoing Transcatheter Aortic Valve Implantation in Germany: A Retrospective Observational Study.
     Int J Cardiol. 2017 Mar 2. pii: S0167-5273(17)31288.
     PubMed     Text format     Abstract available
     
     
     
112. KLAER J, Mahler A, Scherbakov N, Klug L, et al
     Longer-term impact of hemiparetic stroke on skeletal muscle metabolism-A pilot study.
     Int J Cardiol. 2017;230:241-247.
     PubMed     Text format     Abstract available
     
     
     February 2017
113. PROIETTI M, Lip GY
     Geographical differences in thromboembolic and bleeding risks in patients with non-valvular atrial fibrillation: An ancillary analysis from the SPORTIF trials.
     Int J Cardiol. 2017 Feb 27. pii: S0167-5273(17)30411.
     PubMed     Text format     Abstract available
     
     
     
114. LEE SR, Choi EK, Han KD, Cha MJ, et al
     Trends in the incidence and prevalence of atrial fibrillation and estimated thromboembolic risk using the CHA2DS2-VASc score in the entire Korean population.
     Int J Cardiol. 2017 Feb 13. pii: S0167-5273(16)34726.
     PubMed     Text format     Abstract available
     
     
     
115. GUIMARAES LF, Stone GW, Caixeta A
     Reply: Delayed onset of novel P2Y12 receptor antagonists action post fibrinolysis.
     Int J Cardiol. 2017 Feb 11. pii: S0167-5273(17)30775.
     PubMed     Text format    
     
     
     
116. MASUDA K, Ishizu T, Niwa K, Takechi F, et al
     Increased risk of thromboembolic events in adult congenital heart disease patients with atrial tachyarrhythmias.
     Int J Cardiol. 2017 Feb 5. pii: S0167-5273(17)30680.
     PubMed     Text format     Abstract available
     
     
     
117. MODI R, Patted SV, Halkati PC, Porwal S, et al
     CHA2DS2-VASc-HSF score - New predictor of severity of coronary artery disease in 2976 patients.
     Int J Cardiol. 2017;228:1002-1006.
     PubMed     Text format     Abstract available
     
     
     
118. YUAN X, Du J, Liu Q, Zhang L, et al
     Defining the role of perioperative statin treatment in patients after cardiac surgery: A meta-analysis and systematic review of 20 randomized controlled trials.
     Int J Cardiol. 2017;228:958-966.
     PubMed     Text format     Abstract available
     
     
     January 2017
119. VEDOVATI MC, Verdecchia P, Giustozzi M, Molini G, et al
     Permanent discontinuation of non vitamin K oral anticoagulants in real life patients with non-valvular atrial fibrillation.
     Int J Cardiol. 2017 Jan 19. pii: S0167-5273(16)34180.
     PubMed     Text format     Abstract available
     
     
     
120. KO D, Thigpen JL, Otis JA, Forster K, et al
     Influence of statin therapy at time of stroke onset on functional outcome among patients with atrial fibrillation.
     Int J Cardiol. 2017;227:808-812.
     PubMed     Text format     Abstract available
     
     
     
121. SUZUKI M, Takanashi S, Ohshima Y, Nagatomo Y, et al
     Critical potential of early cardiac surgery for infective endocarditis with cardio-embolic strokes.
     Int J Cardiol. 2017;227:222-224.
     PubMed     Text format     Abstract available
     
     
     December 2016
122. GUIMARAES LF, Genereux P, Silveira D, Pesaro AE, et al
     P2Y12 receptor inhibition with prasugrel and ticagrelor in STEMI patients after fibrinolytic therapy: Analysis from the SAMPA randomized trial.
     Int J Cardiol. 2016 Dec 27. pii: S0167-5273(16)34824.
     PubMed     Text format     Abstract available
     
     
     
123. MUSCOGIURI G, Annweiler C, Duval G, Karras S, et al
     Vitamin D and cardiovascular disease: From atherosclerosis to myocardial infarction and stroke.
     Int J Cardiol. 2016 Dec 26. pii: S0167-5273(16)34541.
     PubMed     Text format     Abstract available
     
     
     
124. KAHLERT P, Hildebrandt HA, Patsalis PC, Al-Rashid F, et al
     No protection of heart, kidneys and brain by remote ischemic preconditioning before transfemoral transcatheter aortic valve implantation: Interim-analysis of a randomized single-blinded, placebo-controlled, single-center trial.
     Int J Cardiol. 2016 Dec 6. pii: S0167-5273(16)33752.
     PubMed     Text format     Abstract available
     
     
     November 2016
125. LEE CH, Lin TY, Chang SH, Chen CH, et al
     Body mass index is an independent predictor of major bleeding in non-valvular atrial fibrillation patients taking dabigatran.
     Int J Cardiol. 2016;228:771-778.
     PubMed     Text format     Abstract available
     
     
     
126. WYBRANIEC MT, Faryan M, Kusz B, Lasek-Bal A, et al
     CHA2DS2-VASC-AF2 score accurately predicts moderate-to-severe acute neurological dysfunction in the course of first ever ischaemic stroke.
     Int J Cardiol. 2016;228:286-288.
     PubMed     Text format    
     
     
     
127. WONG CK
     Simplifying electrocardiographic assessment in STEMI reperfusion management: Pros and cons.
     Int J Cardiol. 2016;227:30-36.
     PubMed     Text format     Abstract available
     
     
     
128. SASAI M, Iso Y, Mizukami T, Tomosugi N, et al
     Potential contribution of the hepcidin-macrophage axis to plaque vulnerability in acute myocardial infarction in human.
     Int J Cardiol. 2016;227:114-121.
     PubMed     Text format     Abstract available
     
     
     
129. BECATTINI C, Franco L, Beyer-Westendorf J, Masotti L, et al
     Major bleeding with vitamin K antagonists or direct oral anticoagulants in real-life.
     Int J Cardiol. 2016 Nov 9. pii: S0167-5273(16)33576.
     PubMed     Text format     Abstract available
     
     
     
130. ZHOU X, Cao K, Kou S, Qu S, et al
     Usefulness of CHADS2 score for prognostic stratification of patients with coronary artery disease: A systematic review and meta-analysis of cohort studies.
     Int J Cardiol. 2016;228:906-911.
     PubMed     Text format     Abstract available
     
     
     
131. ZHU W, Fu L, Ding Y, Huang L, et al
     Meta-analysis of ATRIA versus CHA2DS2-VASc for predicting stroke and thromboembolism in patients with atrial fibrillation.
     Int J Cardiol. 2016 Nov 9. pii: S0167-5273(16)33445.
     PubMed     Text format     Abstract available
     
     
     
132. GUIMARAES PO, Wojdyla DM, Alexander JH, Thomas L, et al
     Anticoagulation therapy and clinical outcomes in patients with recently diagnosed atrial fibrillation: Insights from the ARISTOTLE trial.
     Int J Cardiol. 2016 Nov 7. pii: S0167-5273(16)33444.
     PubMed     Text format     Abstract available
     
     
     October 2016
133. NAVARESE EP, Kolodziejczak M, Winter MP, Alimohammad A, et al
     Association of PCSK9 with platelet reactivity in patients with acute coronary syndrome treated with prasugrel or ticagrelor: The PCSK9-REACT study.
     Int J Cardiol. 2016 Oct 29. pii: S0167-5273(16)33272.
     PubMed     Text format     Abstract available
     
     
     September 2016
134. SCHMIDT M, Ulrichsen SP, Pedersen L, Botker HE, et al
     30-year nationwide trends in incidence of atrial fibrillation in Denmark and associated 5-year risk of heart failure, stroke, and death.
     Int J Cardiol. 2016;225:30-36.
     PubMed     Text format     Abstract available
     
     
     
135. CHUGH Y, Faillace RT
     The C of CHADS: Historical perspective and clinical applications for anticoagulation in patients with non valvular atrial fibrillation and congestive heart failure.
     Int J Cardiol. 2016;224:431-436.
     PubMed     Text format     Abstract available
     
     
     
136. RUSSO V, Di Napoli L, Bianchi V, Tavoletta V, et al
     A new integrated strategy for direct current cardioversion in non-valvular atrial fibrillation patients using short term rivaroxaban administration: The MonaldiVert real life experience.
     Int J Cardiol. 2016;224:454-455.
     PubMed     Text format    
     
     
     
137. INDRARATNA P, Tian DH, Yan TD, Doyle MP, et al
     Transcatheter aortic valve implantation versus surgical aortic valve replacement: A meta-analysis of randomized controlled trials.
     Int J Cardiol. 2016;224:382-387.
     PubMed     Text format     Abstract available
     
     
     
138. AKCAY M, Soylu K, Yanik A
     Acute thrombotic left main coronary artery; treatment with low dose slow infusion tPA.
     Int J Cardiol. 2016;224:265-266.
     PubMed     Text format    
     
     
     
139. TAKEUCHI D, Inai K, Shinohara T, Nakanishi T, et al
     Blood coagulation abnormalities and the usefulness of D-dimer level for detecting intracardiac thrombosis in adult Fontan patients.
     Int J Cardiol. 2016;224:139-144.
     PubMed     Text format     Abstract available
     
     
     August 2016
140. KATZ M, Bosworth HB, Lopes RD, Dupre ME, et al
     A time-series analysis of the relation between unemployment rate and hospital admission for acute myocardial infarction and stroke in Brazil over more than a decade.
     Int J Cardiol. 2016;224:33-36.
     PubMed     Text format     Abstract available
     
     
     
141. DZIEWIERZ A, Siudak Z, Tokarek T, Rakowski T, et al
     Determinants of stroke following percutaneous coronary intervention in acute myocardial infarction (from ORPKI Polish National Registry).
     Int J Cardiol. 2016;223:236-238.
     PubMed     Text format    
     
     
     
142. SANI M, Ayubi E, Mansori K, Khazaei S, et al
     Predictive ability of HAS-BLED, HEMORR2HAGES, and ATRIA bleeding risk scores in patients with atrial fibrillation: Methodological issues of prediction models.
     Int J Cardiol. 2016;222:949.
     PubMed     Text format    
     
     
     
143. HUMBERT X, Roule V, Chequel M, Fedrizzi S, et al
     Non-vitamin K oral anticoagulant treatment in elderly patients with atrial fibrillation and coronary heart disease.
     Int J Cardiol. 2016 Aug 4. pii: S0167-5273(16)31605.
     PubMed     Text format     Abstract available
     
     
     
144. HUGO GS, Figueiras-Graillet LM, Anguita M, Marin F, et al
     Oral anticoagulation in octogenarians with atrial fibrillation.
     Int J Cardiol. 2016;223:87-90.
     PubMed     Text format     Abstract available
     
     
     
145. BEDEIR K, Giugliano RP, Ramlawi B
     Chronic anticoagulation in non-valvular atrial fibrillation: Where things stand.
     Int J Cardiol. 2016;222:615-619.
     PubMed     Text format     Abstract available
     
     
     
146. KIM Y, Lee SH
     Embolic stroke and after-admission atrial fibrillation.
     Int J Cardiol. 2016;222:576-580.
     PubMed     Text format     Abstract available
     
     
     
147. ERGUN G, Basaran O, Dogan V, Dogan MM, et al
     Obesity and atrial fibrillation.
     Int J Cardiol. 2016;223:159-160.
     PubMed     Text format    
     
     
     
148. ELGENDY IY, Mahmoud AN, Mansoor H, Mojadidi MK, et al
     Evolution of acute ischemic stroke therapy from lysis to thrombectomy: Similar or different to acute myocardial infarction?
     Int J Cardiol. 2016;222:441-447.
     PubMed     Text format     Abstract available
     
     
     
149. CANOY D, Cairns BJ, Balkwill A, Wright FL, et al
     Hypertension in pregnancy and risk of coronary heart disease and stroke: A prospective study in a large UK cohort.
     Int J Cardiol. 2016;222:1012-1018.
     PubMed     Text format     Abstract available
     
     
     July 2016
150. SAITO I, Yamagishi K, Kokubo Y, Yatsuya H, et al
     Association between mortality and incidence rates of coronary heart disease and stroke: The Japan Public Health Center-based prospective (JPHC) study.
     Int J Cardiol. 2016;222:281-286.
     PubMed     Text format     Abstract available
     
     
     
151. PATZER J, Oqab Z, McIntyre WF, Hopman WM, et al
     Cardiology residents' anticoagulation preferences for stroke prophylaxis in atrial fibrillation patients.
     Int J Cardiol. 2016;223:63-64.
     PubMed     Text format    
     
     
     
152. ENGDAHL J, Holmen A, Svennberg E, Friberg L, et al
     Geographic and socio-demographic differences in uptake of population-based screening for atrial fibrillation: The STROKESTOP I study.
     Int J Cardiol. 2016;222:430-435.
     PubMed     Text format     Abstract available
     
     
     
153. GARG L, Chen C, Haines DE
     Atrial fibrillation and chronic kidney disease requiring hemodialysis - Does warfarin therapy improve the risks of this lethal combination?
     Int J Cardiol. 2016;222:47-50.
     PubMed     Text format     Abstract available
     
     
     
154. SENOO K, Lip GY
     Predictive abilities of the HAS-BLED and ORBIT bleeding risk scores in non-warfarin anticoagulated atrial fibrillation patients: An ancillary analysis from the AMADEUS trial.
     Int J Cardiol. 2016;221:379-382.
     PubMed     Text format     Abstract available
     
     
     June 2016
155. PAGNESI M, Martino EA, Chiarito M, Mangieri A, et al
     Silent cerebral injury after transcatheter aortic valve implantation and the preventive role of embolic protection devices: A systematic review and meta-analysis.
     Int J Cardiol. 2016;221:97-106.
     PubMed     Text format     Abstract available
     
     
     
156. CHOI EJ, Lee IH, Je NK
     Inadequate stroke prevention in Korean atrial fibrillation patients in the post-warfarin era.
     Int J Cardiol. 2016;220:647-652.
     PubMed     Text format     Abstract available
     
     
     
157. PALOMAKI A, Kiviniemi T, Mustonen P, Odei C, et al
     Mortality after stroke in patients with paroxysmal and chronic atrial fibrillation - The FibStroke study.
     Int J Cardiol. 2016 Jun 23. pii: S0167-5273(16)31117.
     PubMed     Text format     Abstract available
     
     
     
158. XIA SJ, Du X, Li C, Wu JH, et al
     Uptake of evidence-based statin therapy among atrial fibrillation patients in China: A report from the CAFR (Chinese Atrial Fibrillation Registry) Study.
     Int J Cardiol. 2016;220:284-289.
     PubMed     Text format     Abstract available
     
     
     
159. ROKOS J, Heger M, Stollberger C, Finsterer J, et al
     Bipolar disorder, ischemic stroke, mitral valve vegetation and recurrent venous thrombosis due to antiphospholipid syndrome despite rivaroxaban.
     Int J Cardiol. 2016;221:383-384.
     PubMed     Text format    
     
     
     
160. RICCI RP, Vaccari D, Morichelli L, Zanotto G, et al
     Stroke incidence in patients with cardiac implantable electronic devices remotely controlled with automatic alerts of atrial fibrillation. A sub-analysis of the HomeGuide study.
     Int J Cardiol. 2016;219:251-256.
     PubMed     Text format     Abstract available
     
     
     
161. COLANTONIO LD, Gamboa CM, Kleindorfer DO, Carson AP, et al
     Stroke symptoms and risk for incident coronary heart disease in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.
     Int J Cardiol. 2016;220:122-128.
     PubMed     Text format     Abstract available
     
     
     May 2016
162. TONG Y, Cai L, Zhang YW, Lin L, et al
     Role of functional polymorphisms of the IL-10 gene promoter in the risk of ischemic stroke in Chinese Uyghur population: One case-control study.
     Int J Cardiol. 2016;211:58-60.
     PubMed     Text format    
     
     
     April 2016
163. RICCI F, Di Castelnuovo A, Savarese G, Perrone Filardi P, et al
     ACE-inhibitors versus angiotensin receptor blockers for prevention of events in cardiovascular patients without heart failure - A network meta-analysis.
     Int J Cardiol. 2016;217:128-134.
     PubMed     Text format     Abstract available
     
     
     
164. STOLLBERGER C, Finsterer J, Schneider B
     Is left atrial appendage closure useful for stroke prevention in atrial fibrillation patients with renal failure?
     Int J Cardiol. 2016;216:186-187.
     PubMed     Text format    
     
     
     
165. ALBERTS MJ, Peacock WF, Fields LE, Bunz TJ, et al
     Association between once- and twice-daily direct oral anticoagulant adherence in nonvalvular atrial fibrillation patients and rates of ischemic stroke.
     Int J Cardiol. 2016;215:11-13.
     PubMed     Text format    
     
     
     
166. XIE XX, Liu P, Wan FY, Lin SG, et al
     Blood pressure lowering and stroke events in type 2 diabetes: A network meta-analysis of randomized controlled trials.
     Int J Cardiol. 2016;208:141-6.
     PubMed     Text format    
     
     
     March 2016
167. KOUNIS NG, Grapsas N, Soufras GD, Lianas D, et al
     Clinical and subclinical leaflet thrombosis in bioprosthetic aortic valves: A manifestation of Kounis syndrome?
     Int J Cardiol. 2016;214:86-87.
     PubMed     Text format    
     
     
     
168. EFTEKHARI A, Damgaard D, Grove EL
     Fatal stroke following treatment with apixaban in a patient with atrial fibrillation and left atrial appendage thrombus.
     Int J Cardiol. 2016;214:131-132.
     PubMed     Text format    
     
     
     
169. WATANABE E, Yamamoto M, Kodama I, Inoue H, et al
     Net clinical benefit of adding aspirin to warfarin in patients with atrial fibrillation: Insights from the J-RHYTHM Registry.
     Int J Cardiol. 2016;212:311-317.
     PubMed     Text format     Abstract available
     
     
     
170. COLEMAN CI, Tangirala M, Evers T
     Medication adherence to rivaroxaban and dabigatran for stroke prevention in patients with non-valvular atrial fibrillation in the United States.
     Int J Cardiol. 2016;212:171-173.
     PubMed     Text format    
     
     
     
171. TONG Y, Huang X, Wang Z, Han S, et al
     Effects of functional genetic variants in PPARdelta encoding peroxisome proliferator-activated receptor delta on the risk of ischemic stroke in Chinese Han population.
     Int J Cardiol. 2016;207:297-9.
     PubMed     Text format    
     
     
     
172. DELLBORG M, Eriksson P
     Randomized trials of closure of persistent foramen ovale (PFO) vs medical therapy for patients with cryptogenic stroke - Effect of lost-to-follow-up and withdrawal of consent.
     Int J Cardiol. 2016;207:308-9.
     PubMed     Text format    
     
     
     February 2016
173. YIP HK, Yuen CM, Chen KH, Chai HT, et al
     Tissue plasminogen activator deficiency preserves neurological function and protects against murine acute ischemic stroke.
     Int J Cardiol. 2016;205:133-41.
     PubMed     Text format     Abstract available
     
     
     
174. SEO WK, Kang SH, Jung JM, Choi JY, et al
     Novel composite score to predict atrial Fibrillation in acute stroke patients: AF predicting score in acute stroke.
     Int J Cardiol. 2016;209:184-189.
     PubMed     Text format     Abstract available
     
     
     
175. MELGAARD L, Gorst-Rasmussen A, Sogaard P, Rasmussen LH, et al
     Diabetes mellitus and risk of ischemic stroke in patients with heart failure and no atrial fibrillation.
     Int J Cardiol. 2016;209:1-6.
     PubMed     Text format     Abstract available
     
     
     
176. LEE YB, Jeong SW, Rhee MY, Leem CH, et al
     Aorta-to-arm pulse wave transit time ratio: Better prediction of coronary artery disease and stroke than pulse wave velocity.
     Int J Cardiol. 2016;204:1-3.
     PubMed     Text format    
     
     
     January 2016
177. LEE YJ, Park JK, Uhm JS, Kim JY, et al
     Bleeding risk and major adverse events in patients with cancer on oral anticoagulation therapy.
     Int J Cardiol. 2016;203:372-8.
     PubMed     Text format     Abstract available
     
     
     
178. KEFER J, Tzikas A, Freixa X, Shakir S, et al
     Impact of chronic kidney disease on left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation.
     Int J Cardiol. 2016;207:335-340.
     PubMed     Text format     Abstract available
     
     
     
179. PANG J, Zhang Z, Zheng TZ, Bassig BA, et al
     Green tea consumption and risk of cardiovascular and ischemic related diseases: A meta-analysis.
     Int J Cardiol. 2016;202:967-74.
     PubMed     Text format     Abstract available
     
     
     
180. MAR PL, Familtsev D, Ezekowitz MD, Lakkireddy D, et al
     Periprocedural management of anticoagulation in patients taking novel oral anticoagulants: Review of the literature and recommendations for specific populations and procedures.
     Int J Cardiol. 2016;202:578-85.
     PubMed     Text format     Abstract available
     
     
     November 2015
181. GARG J, Chaudhary R, Krishnamoorthy P, Shah N, et al
     Safety and efficacy of uninterrupted periprocedural rivaroxaban in patients undergoing atrial fibrillation catheter ablation: A metaanalysis of 1,362 patients.
     Int J Cardiol. 2015;203:906-908.
     PubMed     Text format    
     
     
     
182. MEYER ML, Jaensch A, Mons U, Breitling LP, et al
     Atrial fibrillation and long-term prognosis of patients with stable coronary heart disease: Relevance of routine electrocardiogram.
     Int J Cardiol. 2015;203:1014-1015.
     PubMed     Text format    
     
     
     
183. MARCUCCI M, Skjoth F, Lip GY, Iorio A, et al
     A decisional model to individualize warfarin recommendations: Expected impact on treatment and outcome rates in a real-world population with atrial fibrillation.
     Int J Cardiol. 2015;203:785-790.
     PubMed     Text format     Abstract available
     
     
     October 2015
184. PALOMAKI A, Mustonen P, Hartikainen JE, Nuotio I, et al
     Strokes after cardioversion of atrial fibrillation - The FibStroke study.
     Int J Cardiol. 2015;203:269-273.
     PubMed     Text format    
     
     
     
185. GARGIULO G, Capodanno D, Sannino A, Barbanti M, et al
     New-onset atrial fibrillation and increased mortality after transcatheter aortic valve implantation: A causal or spurious association?
     Int J Cardiol. 2015;203:264-266.
     PubMed     Text format    
     
     
     September 2015
186. DURHEIM MT, Cyr DD, Lopes RD, Thomas LE, et al
     Chronic obstructive pulmonary disease in patients with atrial fibrillation: Insights from the ARISTOTLE trial.
     Int J Cardiol. 2015;202:589-594.
     PubMed     Text format     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Stroke is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: